Increased stroke size following MCA occlusion in a mouse model of sickle cell disease

Blood

Volumn 123, Issue 12, 2014, Pages 1965-1966

  Luo, Wei ^a   Su, Enming Joseph ^a   Wang, Jintao ^a   Wang, Hui ^a   Guo, Chiao ^a   Pawar, Amrita ^a   Campbell, Andrew D ^a   Lawrence, Daniel A ^a   Eitzman, Daniel T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; DISEASE PREDISPOSITION; ERYTHROCYTE; HUMAN; LETTER; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; PRIORITY JOURNAL; SICKLE CELL; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; SPLENOMEGALY;

ANEMIA, SICKLE CELL; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, MUTANT STRAINS; STROKE;

EID: 84897496547     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-01-549717     Document Type: Letter

References (9)

1. Morris CR. Vascular risk assessment in patients with sickle cell disease. Haematologica. 2011;96(1):1-5.
2. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11-16.
3. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol. 1986;20(6):684-690. (Pubitemid 17207642)
4. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 1972;287(17):846-849.
5. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294. (Pubitemid 28018756)
6. Wu LC, Sun CW, Ryan TM, Pawlik KM, Ren J, Townes TM. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 2006;108(4):1183-1188. (Pubitemid 44232013)
7. Luo W, Campbell A, Wang H, et al. P-selectin glycoprotein ligand-1 inhibition blocks increased leukocyte-endothelial interactions associated with sickle cell disease in mice. Blood. 2012;120(18):3862-3864.
8. Su EJ, Fredriksson L, Geyer M, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med. 2008;14(7):731-737.
9. Li F, Silva MD, Sotak CH, Fisher M. Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T2-weighted MRI. Neurology. 2000;54(3):689-696. (Pubitemid 30082940)